Marshall Wace
AMPE

Marshall Wace’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Marshall Wace’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-130
Closed -$92K – 1100
2015
Q2 		$92K Buy
+130
New +$139K ﹤0.01% 861

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace's AMPE Position: Q3 2015 in Review

Marshall Wace sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2015, closing a stake of 130 shares — an estimated $92K sold.

Marshall Wace first reported a position in AMPE in Q2 2015 and held it in 1 quarter. The position peaked at $92K in Q2 2015. 51 funds tracked by Wall St. Rank hold AMPE as of Q3 2015.

  • Marshall Wace reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2015 after selling out during the quarter.
  • Marshall Wace sold 130 Ampio Pharmaceuticals Inc. shares in Q3 2015, an estimated $92K.
  • Marshall Wace first reported a position in Ampio Pharmaceuticals Inc. in Q2 2015 and held it in 1 quarter.
  • Marshall Wace's Ampio Pharmaceuticals Inc. position peaked at $92K in Q2 2015.
  • 51 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2015.

Based on Marshall Wace's 13F filing for Q3 2015, filed 12 Nov 2015.